Drug maker Shire rejects $63b Takeda bid as Allergan drops pursuit

A blister pack containing Mezavant XL anti-inflammatory tablets, produced by Shire Plc, sits on a pharmacy counter in this arranged photograph in London, U.K., on Thursday, Dec. 29, 2016. Photographer: Chris Ratcliffe/Bloomberg